試す - 無料

Fountain of youth

Healthcare Radius

|

May 2023

The demand for anti-aging products and procedures is going through the roof. Science is helping.

- MOLLY R

Fountain of youth

Is anti-aging more than a pipe dream? Going by the variety of products on the shelves of shops selling cosmetics, it is not. According to Customer Market Research, a market research firm, the global anti-aging market was valued at $60 billion (Rs 4.93 lakh crore, approximately) in 2021 and is expected to double by 2030, reaching $120 billion (about Rs 9.85 lakh crore).

The Asia Pacific anti-aging market stood at 8.09 billion (Rs 66388.84 crore, approximately) in 2022 and is slated to grow by 5.69 percent to reach 10.66 billion (Rs 87,478.46 crore, roughly) by 2027, according to another research firm, Market Data Forecast. The Indian anti-aging market is the fastest-growing and is predicted to grow at a CAGR of 12 percent during the forecast period (2022 to 2027). Changing lifestyles, advancements in cosmetics, and escalating healthcare expenditures are majorly driving this market growth in India.

In 2021, skincare dominated the market, accounting for about 41 percent of the global market share, while haircare and cosmetics accounted for 22 percent and 16 percent, respectively. The expanding economy of India allows consumers to purchase anti-aging products and services, thus, boosting the market growth in both. Also, e-commerce sites and social media present opportunities and attract more customers.

A play of products

Arushi Jain, Director, Akums Drugs & Pharmaceuticals, says, "From anti-aging creams and under-eye creams to hydro-boasting face serums, the market is flooded with skincare products. Some popular formats are anti-aging face cleansers, anti-aging creams, Retinol serums, under-eye creams and serums, face packs, night creams, hydrating toners, and lip serums. Effectiveness of all these depends upon the quality of ingredients chosen to formulate the products."

Healthcare Radius からのその他のストーリー

Healthcare Radius

Healthcare Radius

VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM

Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.

time to read

1 mins

December 2025

Healthcare Radius

Healthcare Radius

A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026

The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.

time to read

12 mins

December 2025

Healthcare Radius

Healthcare Radius

FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA

From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.

time to read

6 mins

December 2025

Healthcare Radius

ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US

Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS

Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL

Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS

By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”

time to read

7 mins

December 2025

Healthcare Radius

Healthcare Radius

MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM

Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.

time to read

1 min

December 2025

Translate

Share

-
+

Change font size